Tag: biomedical
-
Engineered Antibody Delays Type 1 Diabetes Onset
Results from a clinical trial show a synthetic antibody delayed for about 2 years the start of type 1 diabetes symptoms among people at high risk of the disease.
-
Repurposing an Anti-Inflammatory Drug to Treat a Life-Threatening Disease
Researchers successfully identified a common drug compound, a non-steroidal anti-inflammatory, that is active against all growing stages of the parasite that causes schistosomiasis.
-
Gut Microbe Links to Autism Revealed
Lab mice with bacteria transplanted from human intestines show signs that autism behaviors may result from the state of their gut microbes.
-
Strep A Vaccine Project Launched
An international initiative is underway to begin work on a vaccine against group A streptococcus infections becoming resistant to today’s antibiotics.
-
Liquid Biopsy Screening Start-Up Launches, Gains $110M
A new enterprise is starting up, developing early-stage cancer screening with a single blood test, based on research at Johns Hopkins University.
-
Synthetic Cannabidiol Shown to Reduce Seizures
A synthetic form of cannabidiol, or CBD, a derivative of cannabis, is shown in tests with lab rats to reduce the occurrence of seizures from epilepsy.
-
Home Chronic Disease Blood Test in Development
A university chemistry lab and start-up company are developing a home monitoring device that aims to reduce repeated clinic visits by people with chronic diseases.
-
FDA Clears Wearable App Device for Migraine
The Food and Drug Administration authorized a wearable nerve-stimulation device controlled by a mobile app to treat acute migraine headaches.
-
Gold Nanoparticles Boost Crispr Delivery
Cancer researchers designed a technique using gold nanoscale particles for safer delivery of edited gene therapies to blood-forming stem cells.
-
Infographic – Highest Diabetes Rates in U.S.
Statista published a map yesterday showing the states in the U.S. with the highest rates of diabetes, this weekend’s infographic.